Robert A. Beardsley - 24 Feb 2025 Form 3 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Director
Signature
/s/ David C. Hastings as attorney-in-fact for Robert Alan Beardsley
Issuer symbol
ABUS
Transactions as of
24 Feb 2025
Net transactions value
$0
Form type
3
Filing time
06 Mar 2025, 16:10:27 UTC
Previous filing
28 Feb 2023
Next filing
20 Mar 2025

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of attorney